Sale of new oral drug for type 2 diabetes approved
Duvier (lobeglitazone), the second new drug developed by Chong Kun Dang Pharm following Camtobell (belotecam) in 2003, has passed safety and effectiveness tests, becoming the 20t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
